{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T14:38:12Z","timestamp":1780583892494,"version":"3.54.1"},"reference-count":72,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,3,7]],"date-time":"2024-03-07T00:00:00Z","timestamp":1709769600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000050","name":"NHLBI","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000861","name":"Burroughs Wellcome Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000861","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007338","name":"Foundation for Barnes-Jewish Hospital","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007338","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jhltonline.org","clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Heart and Lung Transplantation"],"published-print":{"date-parts":[[2024,8]]},"DOI":"10.1016\/j.healun.2024.02.1459","type":"journal-article","created":{"date-parts":[[2024,3,5]],"date-time":"2024-03-05T16:42:40Z","timestamp":1709656960000},"page":"1235-1240","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["IL-33: Friend or foe in transplantation?"],"prefix":"10.1016","volume":"43","author":[{"given":"Ghandi F.","family":"Hassan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucy S.","family":"Cohen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jen","family":"Alexander-Brett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.healun.2024.02.1459_bib1","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1038\/nri.2016.95","article-title":"Interleukin-33 in health and disease","volume":"16","author":"Liew","year":"2016","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.healun.2024.02.1459_bib2","doi-asserted-by":"crossref","first-page":"3488","DOI":"10.4049\/jimmunol.1101977","article-title":"Endogenous IL-33 is highly expressed in mouse epithelial barrier tissues, lymphoid organs, brain, embryos, and inflamed tissues: in situ analysis using a novel Il-33-LacZ gene trap reporter strain","volume":"188","author":"Pichery","year":"2012","journal-title":"J Immunol"},{"key":"10.1016\/j.healun.2024.02.1459_bib3","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.immuni.2005.09.015","article-title":"IL-33, an Interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper Type 2-associated cytokines","volume":"23","author":"Schmitz","year":"2005","journal-title":"Immunity"},{"key":"10.1016\/j.healun.2024.02.1459_bib4","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.02210-2022","article-title":"Oxidised IL-33 drives COPD epithelial pathogenesis via ST2-independent RAGE\/EGFR signalling complex","volume":"62","author":"Strickson","year":"2023","journal-title":"Eur Respir J"},{"key":"10.1016\/j.healun.2024.02.1459_bib5","doi-asserted-by":"crossref","first-page":"3967","DOI":"10.1172\/JCI65570","article-title":"Long-term IL-33\u2013producing epithelial progenitor cells in chronic obstructive lung disease","volume":"123","author":"Byers","year":"2013","journal-title":"J Clin Investig"},{"key":"10.1016\/j.healun.2024.02.1459_bib6","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.4049\/jimmunol.1700216","article-title":"The innate cytokines IL-25, IL-33, and TSLP cooperate in the induction of Type 2 innate lymphoid cell expansion and mucous metaplasia in rhinovirus-infected immature mice","volume":"199","author":"Han","year":"2017","journal-title":"J Immunol"},{"key":"10.1016\/j.healun.2024.02.1459_bib7","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1111\/imr.12552","article-title":"IL-33: biological properties, functions, and roles in airway disease","volume":"278","author":"Drake","year":"2017","journal-title":"Immunol Rev"},{"key":"10.1016\/j.healun.2024.02.1459_bib8","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1016\/j.immuni.2015.06.006","article-title":"Interleukin-33 in tissue homeostasis, injury, and inflammation","volume":"42","author":"Molofsky","year":"2015","journal-title":"Immunity"},{"key":"10.1016\/j.healun.2024.02.1459_bib9","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1021\/acsptsci.9b00099","article-title":"IL-33 in chronic respiratory disease: from preclinical to clinical studies","volume":"3","author":"Donovan","year":"2020","journal-title":"ACS Pharm Transl Sci"},{"key":"10.1016\/j.healun.2024.02.1459_bib10","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.jaci.2011.09.041","article-title":"Innate IL-13-producing nuocytes arise during allergic lung inflammation and contribute to airways hyperreactivity","volume":"129","author":"Barlow","year":"2012","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.healun.2024.02.1459_bib11","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.4049\/jimmunol.1102832","article-title":"IL-33-responsive lineage- CD25+ CD44(hi) lymphoid cells mediate innate type 2 immunity and allergic inflammation in the lungs","volume":"188","author":"Bartemes","year":"2012","journal-title":"J Immunol"},{"key":"10.1016\/j.healun.2024.02.1459_bib12","doi-asserted-by":"crossref","first-page":"4489","DOI":"10.4049\/jimmunol.1201212","article-title":"IL-33-mediated innate response and adaptive immune cells contribute to maximum responses of protease allergen-induced allergic airway inflammation","volume":"190","author":"Kamijo","year":"2013","journal-title":"J Immunol"},{"key":"10.1016\/j.healun.2024.02.1459_bib13","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.molimm.2014.06.018","article-title":"The role of the IL-33\/IL-1RL1 axis in mast cell and basophil activation in allergic disorders","volume":"63","author":"Saluja","year":"2015","journal-title":"Mol Immunol"},{"key":"10.1016\/j.healun.2024.02.1459_bib14","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.ebiom.2017.03.033","article-title":"A comprehensive evaluation of nasal and bronchial cytokines and chemokines following experimental rhinovirus infection in allergic asthma: increased interferons (IFN-gamma and IFN-lambda) and Type 2 inflammation (IL-5 and IL-13)","volume":"19","author":"Hansel","year":"2017","journal-title":"EBioMedicine"},{"key":"10.1016\/j.healun.2024.02.1459_bib15","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1126\/science.1215418","article-title":"The alarmin interleukin-33 drives protective antiviral CD8(+) T cell responses","volume":"335","author":"Bonilla","year":"2012","journal-title":"Science"},{"key":"10.1016\/j.healun.2024.02.1459_bib16","doi-asserted-by":"crossref","first-page":"4010","DOI":"10.4049\/jimmunol.1400481","article-title":"IL-33 is an unconventional Alarmin that stimulates IL-2 secretion by dendritic cells to selectively expand IL-33R\/ST2+ regulatory T cells","volume":"193","author":"Matta","year":"2014","journal-title":"J Immunol"},{"issue":"3","key":"10.1016\/j.healun.2024.02.1459_bib17","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20221462","article-title":"Regulation of the alveolar regenerative niche by amphiregulin-producing regulatory T cells","volume":"220","author":"Kaiser","year":"2023","journal-title":"J Exp Med"},{"key":"10.1016\/j.healun.2024.02.1459_bib18","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1038\/ni.2131","article-title":"Innate lymphoid cells promote lung-tissue homeostasis after infection with influenza virus","volume":"12","author":"Monticelli","year":"2011","journal-title":"Nat Immunol"},{"key":"10.1016\/j.healun.2024.02.1459_bib19","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1172\/JCI30634","article-title":"IL-33 and ST2 comprise a critical biomechanically induced and cardioprotective signaling system","volume":"117","author":"Sanada","year":"2007","journal-title":"J Clin Invest"},{"key":"10.1016\/j.healun.2024.02.1459_bib20","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1146\/annurev-immunol-101320-124243","article-title":"Emerging functions of IL-33 in homeostasis and immunity","volume":"40","author":"Dwyer","year":"2022","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.healun.2024.02.1459_bib21","doi-asserted-by":"crossref","DOI":"10.3390\/ijms222413288","article-title":"The paradigm change of IL-33 in vascular biology","volume":"22","author":"Demyanets","year":"2021","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.healun.2024.02.1459_bib22","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0088742","article-title":"The alarmin concept applied to human renal transplantation: evidence for a differential implication of HMGB1 and IL-33","volume":"9","author":"Thierry","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.healun.2024.02.1459_bib23","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.744927","article-title":"Endogenous Interleukin-33 acts as an alarmin in liver ischemia-reperfusion and is associated with injury after human liver transplantation","volume":"12","author":"Barbier","year":"2021","journal-title":"Front Immunol"},{"key":"10.1016\/j.healun.2024.02.1459_bib24","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0003331","article-title":"The IL-1-like cytokine IL-33 is constitutively expressed in the nucleus of endothelial cells and epithelial cells in vivo: a novel 'alarmin'?","volume":"3","author":"Moussion","year":"2008","journal-title":"PLoS One"},{"key":"10.1016\/j.healun.2024.02.1459_bib25","doi-asserted-by":"crossref","DOI":"10.1172\/JCI149336","article-title":"Basal epithelial stem cells cross an alarmin checkpoint for postviral lung disease","volume":"131","author":"Wu","year":"2021","journal-title":"J Clin Invest"},{"key":"10.1016\/j.healun.2024.02.1459_bib26","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.aax0416","article-title":"Stromal cells maintain immune cell homeostasis in adipose tissue via production of interleukin-33","volume":"4","author":"Mahlak\u00f5iv","year":"2019","journal-title":"Sci Immunol"},{"key":"10.1016\/j.healun.2024.02.1459_bib27","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1002\/eji.201948413","article-title":"Fibroblast-derived IL-33 is dispensable for lymph node homeostasis but critical for CD8 T-cell responses to acute and chronic viral infection","volume":"51","author":"Aparicio-Domingo","year":"2021","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.healun.2024.02.1459_bib28","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0011944","article-title":"IL-33 is produced by mast cells and regulates IgE-dependent inflammation","volume":"5","author":"Hsu","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.healun.2024.02.1459_bib29","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1189\/jlb.0811425","article-title":"The mouse interleukin (Il)33 gene is expressed in a cell type- and stimulus-dependent manner from two alternative promoters","volume":"91","author":"Talabot-Ayer","year":"2012","journal-title":"J Leukoc Biol"},{"key":"10.1016\/j.healun.2024.02.1459_bib30","doi-asserted-by":"crossref","DOI":"10.1016\/j.cyto.2022.155891","article-title":"Interleukin-33 (IL-33): a critical review of its biology and the mechanisms involved in its release as a potent extracellular cytokine","volume":"156","author":"Cayrol","year":"2022","journal-title":"Cytokine"},{"key":"10.1016\/j.healun.2024.02.1459_bib31","doi-asserted-by":"crossref","first-page":"3244","DOI":"10.1038\/s41467-018-05485-x","article-title":"Chromatin regulates IL-33 release and extracellular cytokine activity","volume":"9","author":"Travers","year":"2018","journal-title":"Nat Commun"},{"key":"10.1016\/j.healun.2024.02.1459_bib32","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1073\/pnas.1115884109","article-title":"IL-33 is processed into mature bioactive forms by neutrophil elastase and cathepsin G","volume":"109","author":"Lefrancais","year":"2012","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.healun.2024.02.1459_bib33","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1164\/rccm.201406-1039OC","article-title":"IL-33-dependent type 2 inflammation during rhinovirus-induced asthma exacerbations in vivo","volume":"190","author":"Jackson","year":"2014","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.healun.2024.02.1459_bib34","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1164\/rccm.200805-666OC","article-title":"Resolution of allergic inflammation and airway hyperreactivity is dependent upon disruption of the T1\/ST2\u2013IL-33 pathway","volume":"179","author":"Kearley","year":"2009","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.healun.2024.02.1459_bib35","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1111\/all.12309","article-title":"IL-33 is a mediator rather than a trigger of the acute allergic response in humans","volume":"69","author":"Fux","year":"2014","journal-title":"Allergy"},{"key":"10.1016\/j.healun.2024.02.1459_bib36","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1038\/s41590-022-01255-6","article-title":"Allergen protease-activated stress granule assembly and gasdermin D fragmentation control interleukin-33 secretion","volume":"23","author":"Chen","year":"2022","journal-title":"Nat Immunol"},{"key":"10.1016\/j.healun.2024.02.1459_bib37","doi-asserted-by":"crossref","first-page":"4375","DOI":"10.4049\/jimmunol.1003020","article-title":"The danger signal, extracellular ATP, is a sensor for an airborne allergen and triggers IL-33 release and innate Th2-type responses","volume":"186","author":"Kouzaki","year":"2011","journal-title":"J Immunol"},{"key":"10.1016\/j.healun.2024.02.1459_bib38","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1111\/all.13158","article-title":"Oxidative stress serves as a key checkpoint for IL-33 release by airway epithelium","volume":"72","author":"Uchida","year":"2017","journal-title":"Allergy"},{"key":"10.1016\/j.healun.2024.02.1459_bib39","article-title":"Epithelial IL-33 appropriates exosome trafficking for secretion in chronic airway disease","volume":"6","author":"Katz-Kiriakos","year":"2021","journal-title":"JCI Insight"},{"key":"10.1016\/j.healun.2024.02.1459_bib40","doi-asserted-by":"crossref","first-page":"7890","DOI":"10.4049\/jimmunol.0802449","article-title":"Caspase-1, caspase-8, and calpain are dispensable for IL-33 release by macrophages","volume":"183","author":"Ohno","year":"2009","journal-title":"J Immunol"},{"key":"10.1016\/j.healun.2024.02.1459_bib41","doi-asserted-by":"crossref","first-page":"8327","DOI":"10.1038\/ncomms9327","article-title":"Oxidation of the alarmin IL-33 regulates ST2-dependent inflammation","volume":"6","author":"Cohen","year":"2015","journal-title":"Nat Commun"},{"key":"10.1016\/j.healun.2024.02.1459_bib42","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.immuni.2009.05.007","article-title":"Suppression of interleukin-33 bioactivity through proteolysis by apoptotic caspases","volume":"31","author":"Luthi","year":"2009","journal-title":"Immunity"},{"key":"10.1016\/j.healun.2024.02.1459_bib43","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1161\/01.CIR.0000047274.66749.FE","article-title":"Identification of serum soluble ST2 receptor as a novel heart failure biomarker","volume":"107","author":"Weinberg","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.healun.2024.02.1459_bib44","doi-asserted-by":"crossref","first-page":"e147","DOI":"10.1016\/j.jacc.2013.05.019","article-title":"2013 ACCF\/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines","volume":"62","author":"Yancy","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.healun.2024.02.1459_bib45","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.3390\/biomedicines11061676","article-title":"The ST2\/IL-33 pathway in adult and paediatric heart disease and transplantation","volume":"11","author":"Brunetti","year":"2023","journal-title":"Biomedicines"},{"key":"10.1016\/j.healun.2024.02.1459_bib46","doi-asserted-by":"crossref","first-page":"250","DOI":"10.3109\/1354750X.2013.773081","article-title":"Interleukin receptor family member ST2 concentrations in patients following heart transplantation","volume":"18","author":"Januzzi","year":"2013","journal-title":"Biomarkers"},{"key":"10.1016\/j.healun.2024.02.1459_bib47","doi-asserted-by":"crossref","first-page":"2118","DOI":"10.1016\/j.athoracsur.2011.07.048","article-title":"Soluble ST2 is a marker for acute cardiac allograft rejection","volume":"92","author":"Pascual-Figal","year":"2011","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.healun.2024.02.1459_bib48","doi-asserted-by":"crossref","DOI":"10.1111\/ctr.13349","article-title":"Elevated ST2 levels are associated with antibody-mediated rejection in heart transplant recipients","volume":"32","author":"Grupper","year":"2018","journal-title":"Clin Transpl"},{"key":"10.1016\/j.healun.2024.02.1459_bib49","doi-asserted-by":"crossref","first-page":"811","DOI":"10.4070\/kcj.2016.46.6.811","article-title":"Role of soluble ST2 as a marker for rejection after heart transplant","volume":"46","author":"Lee","year":"2016","journal-title":"Korean Circ J"},{"key":"10.1016\/j.healun.2024.02.1459_bib50","doi-asserted-by":"crossref","DOI":"10.1111\/ctr.14616","article-title":"Suppression of tumorigenicity-2 (ST2) is a promising biomarker in heart transplantation","volume":"36","author":"Galeone","year":"2022","journal-title":"Clin Transpl"},{"key":"10.1016\/j.healun.2024.02.1459_bib51","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1111\/ajt.13542","article-title":"Elevated ST2 distinguishes incidences of pediatric heart and small bowel transplant rejection","volume":"16","author":"Mathews","year":"2016","journal-title":"Am J Transpl"},{"key":"10.1016\/j.healun.2024.02.1459_bib52","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.yjmcc.2013.03.020","article-title":"Components of the interleukin-33\/ST2 system are differentially expressed and regulated in human cardiac cells and in cells of the cardiac vasculature","volume":"60","author":"Demyanets","year":"2013","journal-title":"J Mol Cell Cardiol"},{"key":"10.1016\/j.healun.2024.02.1459_bib53","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.118.005488","article-title":"Pulmonary production of soluble ST2 in heart failure","volume":"11","author":"Pascual-Figal","year":"2018","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.healun.2024.02.1459_bib54","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1111\/j.1432-2277.2011.01306.x","article-title":"Interleukin-33 prolongs allograft survival during chronic cardiac rejection","volume":"24","author":"Brunner","year":"2011","journal-title":"Transpl Int"},{"key":"10.1016\/j.healun.2024.02.1459_bib55","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1097\/TP.0b013e3181d720af","article-title":"IL-33 prolongs murine cardiac allograft survival through induction of TH2-Type immune deviation","volume":"89","author":"Yin","year":"2010","journal-title":"Transplantation"},{"key":"10.1016\/j.healun.2024.02.1459_bib56","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1038\/labinvest.2016.54","article-title":"Recombinant IL-33 prolongs leflunomide-mediated graft survival by reducing IFN-\u03b3 and expanding CD4+Foxp3+ T cells in concordant heart transplantation","volume":"96","author":"Dai","year":"2016","journal-title":"Lab Investig"},{"key":"10.1016\/j.healun.2024.02.1459_bib57","doi-asserted-by":"crossref","first-page":"4598","DOI":"10.4049\/jimmunol.1100519","article-title":"IL-33 expands suppressive CD11b+ Gr-1int and regulatory T cells, including ST2L+ Foxp3+ Cells, and mediates regulatory T cell-dependent promotion of cardiac allograft survival","volume":"187","author":"Turnquist","year":"2011","journal-title":"J Immunol"},{"key":"10.1016\/j.healun.2024.02.1459_bib58","doi-asserted-by":"crossref","first-page":"5397","DOI":"10.1172\/JCI133008","article-title":"Graft IL-33 regulates infiltrating macrophages to protect against chronic rejection","volume":"130","author":"Li","year":"2020","journal-title":"J Clin Investig"},{"key":"10.1016\/j.healun.2024.02.1459_bib59","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1164\/rccm.201707-1368OC","article-title":"Depletion of airway submucosal glands and TP63(+)KRT5(+) basal cells in obliterative bronchiolitis","volume":"197","author":"Swatek","year":"2018","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.healun.2024.02.1459_bib60","article-title":"An obligatory role for club cells in preventing obliterative bronchiolitis in lung transplants","volume":"5","author":"Liu","year":"2019","journal-title":"JCI Insight"},{"key":"10.1016\/j.healun.2024.02.1459_bib61","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2023.111081","article-title":"Trichosanthin-derived peptide Tk-PQ attenuates immune rejection in mouse tracheal allotransplant model by suppressing PI3K-Akt and inducing type II immune polarization","volume":"125","author":"Zhou","year":"2023","journal-title":"Int Immunopharmacol"},{"key":"10.1016\/j.healun.2024.02.1459_bib62","doi-asserted-by":"crossref","first-page":"1963","DOI":"10.1111\/ajt.17084","article-title":"Ischemia reperfusion injury facilitates lung allograft acceptance through IL-33-mediated activation of donor-derived IL-5 producing group 2 innate lymphoid cells","volume":"22","author":"Guo","year":"2022","journal-title":"Am J Transplant"},{"key":"10.1016\/j.healun.2024.02.1459_bib63","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.128241","article-title":"Eosinophils downregulate lung alloimmunity by decreasing TCR signal transduction","volume":"4","author":"Onyema","year":"2019","journal-title":"JCI Insight"},{"key":"10.1016\/j.healun.2024.02.1459_bib64","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.96455","article-title":"Eosinophils promote inducible NOS-mediated lung allograft acceptance","volume":"2","author":"Onyema","year":"2017","journal-title":"JCI Insight"},{"key":"10.1016\/j.healun.2024.02.1459_bib65","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1016\/j.healun.2021.05.015","article-title":"Effects of cold or warm ischemia and ex-vivo lung perfusion on the release of damage associated molecular patterns and inflammatory cytokines in experimental lung transplantation","volume":"40","author":"Hasenauer","year":"2021","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2024.02.1459_bib66","doi-asserted-by":"crossref","first-page":"3967","DOI":"10.1172\/JCI65570","article-title":"Long-term IL-33-producing epithelial progenitor cells in chronic obstructive lung disease","volume":"123","author":"Byers","year":"2013","journal-title":"J Clin Invest"},{"key":"10.1016\/j.healun.2024.02.1459_bib67","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.168911","article-title":"Eosinophils restrain humoral alloimmunity after lung transplantation","volume":"9","author":"Mei","year":"2024","journal-title":"JCI Insight"},{"key":"10.1016\/j.healun.2024.02.1459_bib68","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1016\/j.chest.2023.03.033","article-title":"BAL fluid eosinophilia associates with chronic lung allograft dysfunction risk: a multicenter study","volume":"164","author":"Todd","year":"2023","journal-title":"Chest"},{"key":"10.1016\/j.healun.2024.02.1459_bib69","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.healun.2022.09.018","article-title":"IL-33 mediates Pseudomonas induced airway fibrogenesis and is associated with CLAD","volume":"42","author":"Banday","year":"2023","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2024.02.1459_bib70","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.174786","article-title":"Activator protein transcription factors coordinate human IL-33 expression from noncanonical promoters in chronic airway disease","volume":"9","author":"Raphael","year":"2024","journal-title":"JCI Insight"},{"key":"10.1016\/j.healun.2024.02.1459_bib71","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1111\/ajt.15687","article-title":"Pseudomonas aeruginosa and acute rejection independently increase the risk of donor-specific antibodies after lung transplantation","volume":"20","author":"Kulkarni","year":"2020","journal-title":"Am J Transpl"},{"key":"10.1016\/j.healun.2024.02.1459_bib72","doi-asserted-by":"crossref","first-page":"104","DOI":"10.5500\/wjt.v10.i5.104","article-title":"Chronic lung allograft dysfunction post-lung transplantation: the era of bronchiolitis obliterans syndrome and restrictive allograft syndrome","volume":"10","author":"Yoshiyasu","year":"2020","journal-title":"World J Transpl"}],"container-title":["The Journal of Heart and Lung Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1053249824015158?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1053249824015158?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,7,12]],"date-time":"2024-07-12T10:29:56Z","timestamp":1720780196000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1053249824015158"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8]]},"references-count":72,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2024,8]]}},"alternative-id":["S1053249824015158"],"URL":"https:\/\/doi.org\/10.1016\/j.healun.2024.02.1459","relation":{},"ISSN":["1053-2498"],"issn-type":[{"value":"1053-2498","type":"print"}],"subject":[],"published":{"date-parts":[[2024,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"IL-33: Friend or foe in transplantation?","name":"articletitle","label":"Article Title"},{"value":"The Journal of Heart and Lung Transplantation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.healun.2024.02.1459","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Inc. on behalf of International Society for Heart and Lung Transplantation.","name":"copyright","label":"Copyright"}]}}